ArticleBMC cancer2016

Long-lasting reduction in clonogenic potential of colorectal cancer cells by sequential treatments with 5-azanucleosides and topoisomerase inhibitors.

Alicja Pawlak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.